https://gsk-2894631ainhibitor.....com/sars-cov-2-varia
RESULTS there have been no statistical variations in regards to age, sex, and most baseline comorbidities (P0.05). In-hospital outcomes also didn't significantly differ amongst the two teams (P0.05). However, Suture-bicuspidization was related to notably lower tricuspid device event-free survival, and freedom from TR recurrence and tricuspid valve reoperation compared to Ring at 1, 5 and 8 years (all P less then 0.05). After modifying for considerable confounders, Suture-bicuspidization stayed involving nota
Like
Comment
Share
